NCT03236181

Brief Summary

The purpose of this study is to evaluate the effect of dietary fat on satiety (the experience of fullness between one meal and the next) and energy metabolism over an extended period of time (chronic effects). How dietary fat sources affect satiety, appetite and energy use is unclear. The investigators will use a controlled setting for the studies. They want to know if the source of dietary fat alters satiety, satiety hormones, and energy expenditure responses after consuming different diets.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 1, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

October 3, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 24, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 24, 2018

Completed
Last Updated

August 3, 2018

Status Verified

August 1, 2018

Enrollment Period

8 months

First QC Date

July 28, 2017

Last Update Submit

August 1, 2018

Conditions

Keywords

Energy ExpenditureAppetiteSatiety

Outcome Measures

Primary Outcomes (1)

  • Acute effect of fat intake on energy expenditure as determined by metabolic rate

    Incremental Area Under the Curve (iAUC) of metabolic rate from 0 to 4 hours

Study Arms (4)

Saturated Fat/SFA

OTHER

30 grams saturated fat (SFA) in the form of heavy whipping cream will be provided to subject in a mixed meal shake

Other: SFA

Monounsaturated Fat/MUFA

OTHER

30 grams monounsaturated fat (MUFA) in the form of olive oil will be provided to subject in a mixed meal shake

Other: MUFA

Polyunsaturated Fat Linoleic/PUFA

OTHER

30 grams high linoleic polyunsaturated fat (PUFA) in the form of high linoleic sunflower oil will be provided to subject in a mixed meal shake

Other: PUFA

Polyunsaturated Fat Omega-3/LCn3

OTHER

30 grams high omega-3 polyunsaturated fat (LCn3) in the form of fish oil will be provided to subject in a mixed meal shake

Other: LCn3

Interventions

SFAOTHER

High saturated fatty acid/SFA oil source

Saturated Fat/SFA
MUFAOTHER

High monounsaturated fatty acid/MUFA oil source

Monounsaturated Fat/MUFA
PUFAOTHER

High polyunsaturated fatty acid (linoleic)/PUFA oil source

Polyunsaturated Fat Linoleic/PUFA
LCn3OTHER

High polyunsaturated fatty acid (omega-3)/LCn3 oil source

Polyunsaturated Fat Omega-3/LCn3

Eligibility Criteria

Age20 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • body mass index between 25.0-34.9 kg/m2
  • free of major diagnosed, untreated medical conditions
  • non-smoking or use of other tobacco products, including e-cigarettes
  • not taking steroid-based medications
  • not planning to or currently attempting to gain or lose weight
  • willing to comply with study demands
  • low intake of long chain omega-3 fatty acids (\<0.10 g/d) or willing to reduce intake for 6 weeks prior to starting the study

You may not qualify if:

  • diagnosed eating disorders
  • diabetes (blood sugar ≥ 126 mg/dl)
  • hypertension (systolic \> 160 mmHg or diastolic \> 100 mmHg)
  • diagnosed cardiovascular, pulmonary, skeletal and metabolic diseases
  • currently pregnant or planning to become pregnant, or lactating
  • taking medications known to affect appetite, blood lipids, body composition, body weight, or food intake (appetite control drugs, steroids, antidepressants)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USDA Grand Forks Human Nutrition Research Center

Grand Forks, North Dakota, 58203, United States

Location

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Susan Raatz, PhD

    USDA Grand Forks Human Nutrition Research Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2017

First Posted

August 1, 2017

Study Start

October 3, 2017

Primary Completion

May 24, 2018

Study Completion

May 24, 2018

Last Updated

August 3, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations